Filings Intelligence
Company filings profile · CIK 0001821586

MoonLake Immunotherapeutics — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for MoonLake Immunotherapeutics (MLTX): 10 filings in the last 90 days vs 29 in the prior 90 (filing-velocity cooling ↓ · 0.34×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Nov 5, 2026. Source-linked, daily-refreshed.

Material 8-K events — MoonLake Immunotherapeutics

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
Nov 4, 2026Results of Operations (earnings); Financial Statements and Exhibits↗
Sep 30, 2026Other Events↗
Aug 10, 2026Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits↗
Jul 15, 2026Other Events↗
Jun 25, 2026Entry into a Material Agreement; Financial Statements and Exhibits↗
Jun 22, 2026Regulation FD Disclosure; Other Events; Financial Statements and Exhibits↗
Jun 9, 2026Departure/Election of Directors or Officers; Item 5.07; Financial Statements and Exhibits↗
Jun 1, 2026Entry into a Material Agreement↗
May 11, 2026Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits↗

Watch MoonLake Immunotherapeutics automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Watch this company →See a sample alert

Insider transactions (Form 4 / 3 / 5)

FiledForm
Jul 29, 20264↗
Jul 23, 20264↗
Jul 21, 20264↗
Jul 20, 20264↗
Jul 13, 20264↗
Jul 2, 20264↗
Jun 23, 20264↗
Jun 22, 20264↗
Jun 18, 20264↗
Jun 18, 20264↗
Jun 18, 20264↗
Jun 18, 20264↗
Jun 18, 20264↗
Jun 17, 20264↗
May 13, 20264↗
Apr 16, 20264↗
Apr 14, 20264↗
Apr 10, 20264↗
Apr 2, 20264↗
Jan 9, 20264↗

Recent filings

FiledFormDetail
Nov 4, 202610-Q 10-Q ↗
Nov 4, 20268-K Results of Operations (earnings); Financial Statements and Exhibits ↗
Sep 30, 20268-K Other Events ↗
Aug 14, 2026SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G ↗
Aug 14, 2026SCHEDULE 13G/A ↗
Aug 10, 2026S-8 REGISTRATION STATEMENT ↗
Aug 10, 2026S-3ASR REGISTRATION STATEMENT ↗
Aug 10, 202610-Q 10-Q ↗
Aug 10, 20268-K Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits ↗
Jul 29, 20264 ↗
Jul 23, 20264 ↗
Jul 21, 20264 ↗
Jul 20, 20264 ↗
Jul 15, 2026144 ↗
Jul 15, 20268-K Other Events ↗
Jul 13, 20264 ↗
Jul 2, 20264 ↗
Jun 30, 2026144 ↗
Jun 29, 2026SCHEDULE 13D/A ↗
Jun 25, 20268-K Entry into a Material Agreement; Financial Statements and Exhibits ↗
Jun 24, 2026424B5 PROSPECTUS SUPPLEMENT ↗
Jun 23, 20264 ↗
Jun 22, 2026424B5 PRELIMINARY PROSPECTUS SUPPLEMENT ↗
Jun 22, 20264 OWNERSHIP DOCUMENT ↗
Jun 22, 20268-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits ↗
Jun 18, 20264 ↗
Jun 18, 20264 ↗
Jun 18, 20264 ↗
Jun 18, 20264 ↗
Jun 18, 20264 ↗
Jun 17, 20264 ↗
Jun 15, 2026144 ↗
Jun 9, 20268-K Departure/Election of Directors or Officers; Item 5.07; Financial Statements and Exhibits ↗
Jun 1, 20268-K Entry into a Material Agreement ↗
May 15, 2026SCHEDULE 13G/A ↗
May 13, 20264 ↗
May 11, 202610-Q 10-Q ↗
May 11, 20268-K Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits ↗
Apr 21, 2026ARS ARS ↗